Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LAMA2 Retrospective Review of Medical Charts in Infants & Toddlers With LAMA2-Congenital Muscular Dystrophy

NCT04299321 is registered in ClinicalTrials.gov with Prothelia, Inc. as lead sponsor.

NCT NCT04299321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LAMA2 Retrospective Review of Medical Charts in Infants & Toddlers With LAMA2-Congenital Muscular Dystrophy
Lead sponsor
Prothelia, Inc.
Phase
Observational
Overall status
Completed
Start date
April 24, 2020
Completion date
December 31, 2021
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

merosin deficient congenital muscular dystrophy